Charles Robb
2020
In 2020, Charles Robb earned a total compensation of $2.9M as Chief Business Officer and Secretary at Corcept Therapeutics, a 12% increase compared to previous year.
Compensation breakdown
Bonus | $321,236 |
---|---|
Option Awards | $2,118,822 |
Salary | $474,380 |
Total | $2,914,438 |
Robb received $2.1M in option awards, accounting for 73% of the total pay in 2020.
Robb also received $321.2K in bonus and $474.4K in salary.
Rankings
In 2020, Charles Robb's compensation ranked 3,974th out of 13,090 executives tracked by ExecPay. In other words, Robb earned more than 69.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,974 | 70th |
Manufacturing | 1,592 | 72nd |
Chemicals And Allied Products | 603 | 73rd |
Drugs | 521 | 73rd |
Pharmaceutical Preparations | 395 | 73rd |
Robb's colleagues
We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2020.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019